Covered recipient · General Payments record
KENNETH ROY PENDERGRAST
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2019
$515.14
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $183.46 | 11 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $71.43 | 4 |
| Acerta Pharma LLC | $30.93 | 2 |
| Novo Nordisk AS | $29.30 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.11 | 1 |
| ABBVIE INC. | $16.55 | 1 |
| Janssen Pharmaceuticals, Inc | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $16.55 | 07/31/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648097027 | CMS |
| Amgen Inc. | $18.42 | 02/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662600825 | CMS |
| Amgen Inc. | $17.11 | 03/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662600827 | CMS |
| Amgen Inc. | $17.98 | 07/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662600829 | CMS |
| Amgen Inc. | $17.92 | 07/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | 662600823 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.87 | 04/18/2019 | Food and Beverage | Undisputed | 01/23/2026 | 685590189 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.06 | 05/20/2019 | Food and Beverage | Undisputed | 01/23/2026 | 685725735 | CMS |
| Janssen Pharmaceuticals, Inc | $13.14 | 09/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | 659181953 | CMS |
| Novartis Pharmaceuticals Corporation | $22.11 | 12/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | 659862193 | CMS |
| Novo Nordisk Inc | $16.16 | 06/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 674456985 | CMS |
| Novo Nordisk Inc | $13.14 | 07/29/2019 | Food and Beverage | Undisputed | 01/23/2026 | 674495359 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.